Biogen's Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings Why Is Biogen Stock Trading Higher On Wednesday?
benzinga.com/general/biotech/24/04/38410191/biogens-leqembi-commercial-ramp-up-modest-but-up-ticking-reports-mixed-bag-q1-earnings
On Wednesday, Biogen Inc BIIB reported first-quarter adjusted EPS of $3.67, up 8%, beating the consensus of $3.44.
The company reported sales of $2.29 billion, down 7% year over year and missing the consensus of $2.31 billion.
Multiple sclerosis revenue of $1.1 billion decreased by 4% (down 4% on constant currency). Multiple sclerosis drug Tysabri sales were down to $431.3…
This story appeared on benzinga.com, .